ARCHIVES

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

This article is from The Cancer Letter archive.

Vol. 19 No. 43 | November 5, 1993

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director

July 12, 2002

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976